AbbVie Long Term Debt from 2010 to 2025
| ABBV Stock | USD 201.34 7.83 3.74% |
Long Term Debt | First Reported 2011-12-31 | Previous Quarter 58.5 B | Current Value 60.3 B | Quarterly Volatility 22.1 B |
Check AbbVie financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AbbVie's main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.8 B, Interest Expense of 2.9 B or Selling General Administrative of 8.3 B, as well as many indicators such as Price To Sales Ratio of 3.46, Dividend Yield of 0.0288 or PTB Ratio of 99.06. AbbVie financial statements analysis is a perfect complement when working with AbbVie Valuation or Volatility modules.
AbbVie | Long Term Debt |
Latest AbbVie's Long Term Debt Growth Pattern
Below is the plot of the Long Term Debt of AbbVie Inc over the last few years. Long-term debt is a debt that AbbVie Inc has held for over one year. Long-term debt appears on AbbVie Inc balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on AbbVie Inc balance sheet is the sum of the balances of all categories of long-term debt. It is debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years. AbbVie's Long Term Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AbbVie's overall financial position and show how it may be relating to other accounts over time.
| Long Term Debt | 10 Years Trend |
|
Long Term Debt |
| Timeline |
AbbVie Long Term Debt Regression Statistics
| Arithmetic Mean | 36,912,779,464 | |
| Geometric Mean | 15,273,353,297 | |
| Coefficient Of Variation | 66.02 | |
| Mean Deviation | 20,127,376,897 | |
| Median | 36,440,000,000 | |
| Standard Deviation | 24,370,436,547 | |
| Sample Variance | 593918177.5T | |
| Range | 77.5B | |
| R-Value | 0.85 | |
| Mean Square Error | 180487920.4T | |
| R-Squared | 0.72 | |
| Significance | 0.000036 | |
| Slope | 4,332,483,929 | |
| Total Sum of Squares | 8908772662.4T |
AbbVie Long Term Debt History
Other Fundumenentals of AbbVie Inc
AbbVie Long Term Debt component correlations
About AbbVie Financial Statements
AbbVie investors use historical fundamental indicators, such as AbbVie's Long Term Debt, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in AbbVie. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Long Term Debt | 60.3 B | 43 B | |
| Short and Long Term Debt Total | 67.1 B | 51.7 B | |
| Long Term Debt Total | 68 B | 50.1 B | |
| Short and Long Term Debt | 6.8 B | 6.1 B | |
| Long Term Debt To Capitalization | 0.95 | 0.67 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for AbbVie Stock Analysis
When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.